Dp. O'Brien et al., Laminin alpha 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats, J NEUR SCI, 189(1-2), 2001, pp. 37-43
We report laminin alpha2 (merosin) deficiency associated with muscular dyst
rophy and demyelinating neuropathy in two cats. The cats developed progress
ive muscle weakness, and atrophy. Either hypotonia or contractures resulted
in recumbency, necessitating euthanasia. Muscle biopsies showed dystrophic
changes including marked endomysial fibrosis, myofiber necrosis, variabili
ty of fiber size, and perimysial lipid accumulation. Immunohistochemistry s
howed that laminin alpha2 chain was absent or reduced, while dystrophin and
all the components of the dystrophin-associated glycoprotein complex were
present and normal. One cat was examined in detail. Motor nerve conduction
velocity (MNCV) was decreased, and ultrastructurally the peripheral nerves
showed Schwann cell degeneration and demyelination. Brain imaging was not p
erformed, but white matter changes were trot apparent in the brain at necro
psy. The disease in these cats is similar to primary or secondary merosin (
laminin alpha2)-deficient congenital muscular dystrophy (CMD) in humans and
to dystrophia muscularis in mice. (C) 2001 Elsevier Science B.V. All right
s reserved.